Adrenocorticotropic hormone (ACTH) test
≤15 pg/dL or 15-30 pg/dL
The Endocrine Society Guidelines urge clinicians to increase clinical suspicion of hypercortisolism in patients who have overlapping conditions and features, such as difficult-to-control type 2 diabetes (T2D) and hypertension.1
Overlapping conditions and clinical features of Cushing syndrome*Cushing syndrome features in the general population that are common and/or less discriminatory |
---|
Symptoms
Signs
Overlapping conditions
|
Features that best discriminate Cushing syndrome; most do not have a high sensitivity |
|
*Features are listed in random order.
†Cushing syndrome is more likely if onset of the feature is at a younger age.
In the CATALYST study, patients with difficult-to-control T2D were identified as having hypercortisolism if they had:
1-mg post-DST cortisol of >1.8 μg/dL
Confirmed dexamethasone level ≥140 ng/dL
The following tests were used to help identify the potential source of hypercortisolism and inform treatment decisions:
Adrenocorticotropic hormone (ACTH) test
≤15 pg/dL or 15-30 pg/dL
Dehydroepiandrosterone sulfate (DHEAS) test
≤100 μg/dL
Computed tomography (CT)
Abnormal abdominal scan
Referring your patient to an endocrinologist may provide additional clinical confidence in the diagnosis of hypercortisolism.1
Do you have patients who may need a hypercortisolism specialist?
Review treatment options for hypercortisolism
Discuss the recent prevalence data with a Corcept representative
References
1. Nieman LK, Biller BM, Findling JW, et al. J Clin Endocrinol Metab. 2008;93(5):1526-1540. doi:10.1210/jc.2008-0125 2. DeFronzo RA, Auchus RJ, Bancos I, et al. BMJ Open. 2024;14(7):e081121. doi:10.1136/bmjopen-2023-081121